Medexus Pharmaceuticals Inc. (MDP.TO) TSX

2.90

+0.34(+13.28%)

Updated at October 02 04:00PM

Currency In CAD

Valuation

Market Cap43.42M
Enterprise Value56.62M
P/E Ratio82.57
PEG Ratio-1.28
Price/Sales Ratio0.63
Price/Book Ratio1.26
Enterprise/Revenue0.75
Enterprise/EBITDA4.97

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.01
Operating Margin0.05

Management Effectiveness

Return On Assets0.01
Return On Equity0.02

Income Statement

Revenue108.33M
Revenue/Share3.28
Gross Profit56.58M
EBITDA16.81M
Net Income2.25M
Diluted EPS0.08

Balance Sheet

Total Cash9.33M
Total Cash/Share0.29
Total Debt21.9M
Total Debt/Equity0.41
Current Ratio0.81
Book Value Per Share1.64

Price History

52-Week Change12.06
52-Week High5.56
52-Week Low1.71
Moving Average 50 Days2.88
Moving Average 200 Days2.98

Statistics

Average Volume45,723
Shares Outstanding32.26M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:15
Last Split DateDecember 19, 2018